Ob/Gyn Flashcards
Most common cause of unilateral nonbloody nipple discharge?
Inraductal papilloma
Diagnostic testing for nipple discharge?
Mammogram and definitive diagnosis is surgical duct excision. Cytology not helpful.
Bilateral nipple discharge, most likely diagnosis? What test to order?
Most likely prolactinoma. Order prolactin and tsh levels.
20-50 year old woman with cyclical bilateral breast lumps with pain that varies with menstrual cycle. Diagnosis?
Fibrocystic breast disease
Treatment for fibrocystic breast disease?
OCPs, Danazol if severe pain.
Firm, discrete, nontender, highly-mobile breast nodule. FNA shows epithelial and stromal elements. Diagnosis?
Fibroadenoma
Steps for diagnosis of breast mass?
- Clinical breast exam
- U/S or mammography (if patient over 40)
- FNA biopsy
When do you use ultrasound to evaluate breast mass?
If mass feels cystic on palpation, or mass is on younger women with denser breast
Patient with ductal carcinoma in situ (DCIS), what is the treatment?
Lumpectomy (with clear margins) along with radiation therapy and tamoxifen for 5 years
Lobular carcinoma in situ (LCIS), what is the treatment?
Tamoxifen alone for 5 years, don’t have to perform surgery.
Risks associated with tamoxifen use?
Endometrial carcinoma and thromboembolism
Most common form of breast cancer?
Invasive ductal carcinoma (85%), mets to bone, liver, and brain
Second most common form of breast cancer?
Invasive lobular carcinoma (10%), will be bilateral 20% of cases
Red, swollen, warm breast with pitted, edematous skin. Have to rule out?
Inflammatory breast cancer. It metastasizes early
USPSTF breast cancer screening recommendation?
Biennial mammography for women age 50-74
Indications for BRCA1 and BRCA2 gene testing?
- Family history of early-onset (before age 50) breast or ovarian cancer
- Breast and/or ovarian cancer in the same patient
- Family history of male breast cancer
- Ashkenazi Jew
Which hormone receptor confers a greater benefit for adjuvant therapy for breast cancer?
Estrogen. Both estrogen and progesterone positive tumors are the most responsive, however estrogen alone is nearly as good.
MOA of tamoxifen?
SERM. 5 year treatment -> 25% decrease in mortality
MOA of anastrozole, exemestane, letrozole?
Aromatase inhibitors. Blocks peripheral production of estrogen. Standard of care for HR+ postmenopausal women.
Indication for chemotherapy in breast cancer?
Tumor size >1 cm or positive lymph node
Adverse effects of tamoxifen?
- Worsens menopausal symptoms
- Increases risk of endometrial cancer
- Increases risk of thromboembolism
Women with history of of tamoxifen use presents with vaginal bleeding. Next diagnostic step?
Endometrial biopsy, need to rule out endometrial cancer.
Pre or postmenopausal women presents with HR-negative invasive breast cancer. Treatment?
Chemotherapy w/wo Radiation therapy
Premenopausal women presents with HR-positive invasive breast cancer. Treatment?
Chemotherapy w/wo Radiation therapy plus tamoxifen